125 SUMMER STREET, BOSTON, MA
Reports Fourth Quarter and Fiscal 2026 Results; Provides Fiscal 2027 Guidance
Director Departure - Charles J. Dockendorff Will Not Stand for Re-Election
Haemonetics Corporation Repays 0.00% Convertible Senior Notes Due 2026
Haemonetics Corporation Publishes 2024-2025 Corporate Responsibility Report
Reports Third Quarter and Year-to-Date Fiscal 2026 Results; Raises Total Company Fiscal 2026 Guidance
Acquires Vivasure Medical Limited
Reports Second Quarter and First Half Fiscal 2026 Results; Raises Total Company Fiscal 2026 Guidance
Reports First Quarter Fiscal 2026 Results; Reaffirms Fiscal 2026 Guidance
FY 2025
Q3
Q2
Q1
FY 2024
Registration Statement for Securities to be Offered to Employees
Effectiveness Notice
Additional Proxy Materials
Definitive Proxy Statement
Statement of Changes in Beneficial Ownership
Amended Schedule 13G - Ownership Report
Specialized Disclosure Report